Press Releases about Lexaria Bioscience Corp
Lexaria’s Human Oral Nicotine Study Begins Dosing
December 20, 2022
Via ACCESSWIRE
Lexaria Bioscience Corp.’s (NASDAQ: LEXX) 2022 Calendar Year in Review
December 13, 2022
Via ACCESSWIRE
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|